4.65 DESTINY BREAST 04 - A complex trial to deconstruct

Plenary Session - Podcast tekijän mukaan Vinay Prasad, MD MPH

My take on the standing ovation for DESTINY Breast 04 Traztuzumab Deruxtecan vs. Investigator choice after endocrine therapy and 1 or 2 chemotherapies for HER2 low

Visit the podcast's native language site